Very early discharge of LOw-Risk ST elevation myocardial infarction patients after successful primary percutaneous coronary intervention (VEDLOR-STEMI) study.

Refai Showkathali, Radhapriya Yalamanchi, Aishwarya Mahesh Kumar, Sengottuvelu Gunasekaran, Abraham Oomman

Abstract readObservational Study

In one paragraph

Observational study in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Refai ShowkathaliDepartment of Cardiology, Apollo Main Hospital, Chennai, India. Electronic address: refais@gmail.com.

Radhapriya YalamanchiDepartment of Cardiology, Apollo Main Hospital, Chennai, India.

Aishwarya Mahesh KumarDepartment of Medical Services, Apollo Main Hospital, Chennai, India.

Sengottuvelu GunasekaranDepartment of Cardiology, Apollo Main Hospital, Chennai, India.

Abraham OommanDepartment of Cardiology, Apollo Main Hospital, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This VEDLOR-STEMI study assessed the safety and efficacy of very-early discharge (VED- ≤ 48 h) after primary percutaneous coronary intervention (PPCI) for patients with ST elevation myocardial infarction who are considered low risk and compared their outcome with low-risk patients who had standard discharge protocol. No major adverse cardiac events (MACCE) occurred within 6 months. Minor complications, like access site pain were managed without readmission. High patient satisfaction (97.3 %) was noted, with 48 % actively utilizing a hotline for queries. VED post-PPCI appears feasible and safe with appropriate discharge protocols and follow-up.

Indexed as

ElectrocardiographyPatient DischargePercutaneous Coronary InterventionST Elevation Myocardial InfarctionAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeDischarge planningMajor adverse cardiac and cerebral eventsPercutaneous coronary interventionST-Segment elevation myocardial infarction

Identifiers

PMID40250708

DOI10.1016/j.ihj.2025.04.002

PMCPMC12327522

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.